DOCSLIB.ORG

CFS/ME Literature Review (Jan 2004 – Jun 2009)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
CFS/ME Literature Review (Jan 2004 – Jun 2009) CFS/ME Literature Review (Jan 2004 – Jun 2009) A literature review has been included to help inform the workshop participants of the current state of research in the field. A search on Scopus was run using the following search terms and limits: Limits Articles published or entered onto Scopus from 2004 – 2009. Search Terms A search was run using the following search terms: CFS/ME OR chronic fatigue syndrome OR myalgic encephalomyelitis OR myalgic encephalopathy. Autonomic dysfunction inc. cardiovascular abnormalities Van Houdenhove B., Eede F.V.D., Luyten P. Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system? 2009 Medical Hypotheses 72 (6); 701 - 705 http://www.scopus.com/inward/record.url?eid=2-s2.0-62949099218&partnerID=40 Department of Liaison Psychiatry, University Hospitals K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium; Collaborative Antwerp Psychiatric Research Institute, Department of Psychiatry, Antwerp University Hospital, Antwerp, Belgium; Department of Psychology, K.U. Leuven, Leuven, Belgium The etiopathogenesis of chronic fatigue syndrome (CFS) remains poorly understood. Although neuroendocrine disturbances - and hypothalamic-pituitary-adrenal (HPA) axis hypofunction in particular - have been found in a large proportion of CFS patients, it is not clear whether these disturbances are cause or consequence of the illness. After a review of the available evidence we hypothesize that that HPA axis hypofunction in CFS, conceptualized within a system-biological perspective, primarily reflects a fundamental and persistent dysregulation of the neurobiological stress system. As a result, a disturbed balance between glucocorticoid and inflammatory signaling pathways may give rise to a pathological cytokine-induced sickness response that may be the final common pathway underlying central CFS symptoms, i.e. effort/stress intolerance and pain hypersensitivity. This comprehensive hypothesis on HPA axis hypofunction in CFS may stimulate diagnostic refinement of the illness, inform treatment approaches and suggest directions for future research, particularly focusing on the neuroendocrine-immune interface and possible links between CFS, early and recent life stress, and depression. © 2009 Elsevier Ltd. All rights reserved. Smith A.K., Maloney E.M., Falkenberg V.R., Dimulescu I., Rajeevan M.S. An angiotensin-1 converting enzyme polymorphism is associated with allostatic load mediated by C- reactive protein, interleukin-6 and cortisol 2009 Psychoneuroendocrinology 34 (4); 597 – 606 http://www.scopus.com/inward/record.url?eid=2-s2.0-62549098578&partnerID=40 Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne and Enteric Diseases, 1600 Clifton Road, MSG41, Atlanta, GA 30333, United States; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, United States Allostatic load (AL) is a theoretical framework that describes the cumulative physiologic effects of adaptation to change or stress throughout the lifespan. AL is operationalized by a composite index of multiple biomarkers. Accordingly, genes, behavior and environment contribute to AL. To determine if individual differences in AL may be influenced by inherent genetic variation, we calculated an allostatic load index (ALI) for 182 Caucasian subjects derived from a population-based study of chronic fatigue syndrome. Nearly 65% of the subjects in this study sample reported fatiguing illness. ALI was calculated based on 11 measures representing metabolic, cardiovascular, inflammatory, hypothalamic- pituitary-adrenal (HPA) axis and sympathetic nervous system (SNS) activities. Subjects were dichotomized into high (ALI ≥ 3) or low (ALI < 3) AL groups, and the association between high AL and 129 polymorphisms in 32 genes related to the HPA axis, neurotransmission, inflammation, cardiovascular and metabolic functions were evaluated. Polymorphisms in angiotensin-1 converting enzyme (ACE), corticotropin-releasing hormone receptor 1 (CRHR1), and serotonin receptors (HTR3A and HTR4) were associated with AL (p = 0.0007-0.0486), but only one polymorphism, rs4968591, in ACE remained significant after correction for multiple comparisons. The T allele of ACE rs4968591 was more common in subjects with high AL (67.5%) than in subjects with low AL (49.3%) (p = 0.0007), and this effect appeared independent of age, sex, body mass index and fatigue status. Additionally, high interleukin-6 (IL-6; ptrend = 0.04), and C-reactive protein (CRP; ptrend = 0.01) levels, as well as low urinary cortisol levels in females (p = 0.03) were associated with the T allele, which may result in allele-specific binding of the transcription factor, E2F1. Our results suggest a role for ACE in the bidirectional communication between the central nervous and immune systems in response to stress. Further studies will be needed (a) to replicate the association between AL and ACE polymorphisms in population studies designed to differentiate the effects of sex, age and racial/ethnic background, (b) to evaluate the effect of allele-specific binding of E2F1 at rs4968591, and (c) to examine the role of ACE in the co-regulation of CRP, IL-6 and cortisol. Sakudo A., Kato Y.H., Tajima S., Kuratsune H., Ikuta K. Visible and near-infrared spectral changes in the thumb of patients with chronic fatigue syndrome 2009 Clinica Chimica Acta 403 (01-Feb); 163 – 166 http://www.scopus.com/inward/record.url?eid=2-s2.0-64849104310&partnerID=40 Department of Virology, Center for Infectious Disease Control, Research Institute for Microbial Diseases, Yamadaoka, Suita, Osaka, 565-0871, Japan; Fatigue Clinical Center, 21st Century COE Program, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka, 545-8585, Japan; Department of Health Science, Faculty of Health Science for Welfare, Kansai University of Welfare Science, Kashihara, Osaka, 582-0026, Japan Background: Chronic fatigue syndrome (CFS) patients show a persistent fatigue condition with muscle pain and impairment of concentration, memory, and sleep. Presently, the physiological basis of CFS remains unclear. In this study, spectroscopic differences in the thumb were compared between 103 CFS patients and 122 healthy controls to examine possible changes of levels of oxygenated or deoxygenated hemoglobin. Methods: Visible and near-infrared (Vis-NIR) spectroscopy was used to examine possible changes in the region of 600-1100 nm. Results: Vis-NIR spectra showed sharp peaks at 694, 970 and 1060 nm and broad peaks in the regions of 740-760 and 830-850 nm. As these peaks are possibly related to oxyhemoglobin, cytochrome c oxidase and water, levels of these factors were compared between the two groups. Statistical analysis of the absorbance of Vis-NIR spectra showed a significant decrease in water content, a significant increase in oxyhemoglobin content, and a significant increase in the oxidation of heme a + a3 and copper in cytochrome c oxidase in CFS patients. Conclusions: These changes imply accelerated blood flow and energy metabolism in the thumbs of CFS patients. © 2009 Elsevier B.V. All rights reserved. Newton J.L., Sheth A., Shin J., Pairman J., Wilton K., Burt J.A., Jones D.E. Lower ambulatory blood pressure in chronic fatigue syndrome. 2009 Psychosomatic medicine 71 (3); 361 – 365 http://www.scopus.com/inward/record.url?eid=2-s2.0-68549122686&partnerID=40 Cardiovascular Investigation Unit, Institute of Cellular Medicine, Newcastle University, Newcastle NE2 4HH, UK. OBJECTIVE: To examine blood pressure circadian rhythm in subjects with chronic fatigue syndrome (CFS) and appropriate normal and fatigued controls to correlate parameters of blood pressure regulation with perception of fatigue in an observational cohort study. The cause of CFS remains unknown and there are no effective treatments. METHODS: To address whether inactivity was a confounder, we performed a 24-hour ambulatory blood pressure monitoring in the following three subject groups: 1) CFS patients (Fukuda Diagnostic criteria) (n = 38); 2) normal controls (n = 120); and 3) a fatigue comparison group (n = 47) with the autoimmune liver disease primary biliary cirrhosis (PBC). All patients completed a measure of fatigue severity (Fatigue Impact Scale). In view of the different demographics between the patient groups, patients were age- and sex-matched on a case-by- case basis to normal controls and blood pressure parameters were compared. RESULTS: Compared with the control population, the CFS group had significantly lower systolic blood pressure (p < .0001) and mean arterial blood pressure (p = .0002) and exaggerated diurnal variation (p = .009). There was a significant inverse relationship between increasing fatigue and diurnal variation of blood pressure in both the CFS and PBC groups (p < .05). CONCLUSION: Lower blood pressure and abnormal diurnal blood pressure regulation occur in patients with CFS. We would suggest the need for a randomized, placebo-controlled trial of agents to increase blood pressure such as midodrine in CFS patients with an autonomic phenotype. Myhill S., Booth N.E., McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction 2009 International Journal of Clinical and Experimental Medicine 2 (1); 1 – 16 http://www.scopus.com/inward/record.url?eid=2-s2.0-65549089718&partnerID=40 Sarah Myhill Limited, Llangunllo -acty Knighton, Powys LD7 1SL, United Kingdom; Department of Physics, Mansfield College, University of Oxford, Oxford OX1 3RH, United
Load more

Recommended publications
  • The Medical Management of Depression
    The new england journal of medicine review article drug therapy The Medical Management of Depression J. John Mann, M.D. ecurrent episodes of major depression, which is a common From the Department of Neuroscience, and serious illness, are called major depressive disorder; depressive episodes New York State Psychiatric Institute– r Columbia University College of Physicians that occur in conjunction with manic episodes are called bipolar disorder. and Surgeons, New York. Address reprint Major depressive disorder accounts for 4.4 percent of the total overall global disease requests to Dr. Mann at the Department of burden, a contribution similar to that of ischemic heart disease or diarrheal diseases.1 Neuroscience, New York State Psychiatric 2 Institute, 1051 Riverside Dr., Box 42, New The prevalence of major depressive disorder in the United States is 5.4 to 8.9 percent York, NY 10032, or at [email protected]. and of bipolar disorder, 1.7 to 3.7 percent.3 Major depression affects 5 to 13 percent of medical outpatients,4 yet is often undiagnosed and untreated.5,6 Moreover, it is often N Engl J Med 2005;353:1819-34. undertreated when correctly diagnosed.6 Copyright © 2005 Massachusetts Medical Society. The demographics of depression are impressive. Among persons both with major depressive disorder and bipolar disorder, 75 to 85 percent have recurrent episodes.7,8 In addition, 10 to 30 percent of persons with a major depressive episode recover incom- pletely and have persistent, residual depressive symptoms, or dysthymia, a disorder with symptoms
    [Show full text]
  • Allostatic Load - a Challenge to Measure Multisystem Physiological Dysregulation
    National Centre for Research Methods Working Paper 04/12 Allostatic load - a challenge to measure multisystem physiological dysregulation Sanna Read, London School of Hygiene and Tropical Medicine Emily Grundy, University of Cambridge NCRM Working paper 04/12 Allostatic load – a challenge to measure multisystem physiological dysregulation Sanna Read and Emily Grundy London School of Hygiene and Tropical Medicine and University of Cambridge September 2012 Abstract Allostatic load is a sub-clinical dysregulation state, resulting from the body’s response to stress. Allostatic load accumulates gradually over the life course and affects a number of physiological systems. Measuring multisystem dysregulation and changes in it over time is very challenging. In this paper, we discuss composite measures used to capture allostatic load and the challenges involved in deriving and using these measures. Our focus is on measuring allostatic load in later life. Contents 1 Introduction ........................................................................................................................ 2 2 Allostatic load – a multisystem response to stress ............................................................. 2 3 Measures of allostatic load ................................................................................................. 4 4 Measuring processes over time in allostatic load ............................................................... 6 5 Future directions in measuring allostatic load ....................................................................
    [Show full text]
  • Allostatic Load
    Not logged in Talk Contributions Create account Log in Article Talk Read Edit View history Search Wikipedia Allostatic load From Wikipedia, the free encyclopedia Main page This article has multiple issues. Please help improve it or discuss these issues on [hide] Contents the talk page. (Learn how and when to remove these template messages) Featured content This article needs attention from an expert in psychology. (May 2016) Current events This article needs to be updated. (May 2016) Random article Allostatic load is "the wear and tear on the body" which accumulates as an Donate to Wikipedia individual is exposed to repeated or chronic stress. The term was coined by Wikipedia store McEwen and Stellar in 1993. It represents the physiological consequences of chronic exposure to fluctuating or heightened neural or neuroendocrine Interaction response which results from repeated or prolonged chronic stress. Help About Wikipedia Contents [hide] Community portal 1 Regulatory model Recent changes 2 Types Contact page 3 Measurement 4 Relationship to allostasis and homeostasis Tools 5 Reducing risk What links here 6 See also Related changes 7 References The graph represents the effect of increased stress Upload file on the performance of the body. The lower the stress Special pages Regulatory model [ edit ] levels are in the body, the less likely the allostatic load Permanent link model will have a significant effect on the brain and The term allostatic load is "the wear and tear on the body" which accumulates Page information health. Although, an increase in stress levels results in as an individual is exposed to repeated or chronic stress.[1] It was coined by Wikidata item an increase in stress on the brain and the health of McEwen and Stellar in 1993.[2] individuals, making it more likely for the body to have Cite this page The term is part of the regulatory model of allostasis, where the predictive significant effects on homeostasis and cause In other projects regulation or stabilisation of internal sensations in response to stimuli is breakdown of the body systems.
    [Show full text]
  • Polymorphic Regions of the Estrogen Receptor, Androgen Receptor and Serotonin Transporter Genes and Their Association with Mood Variability in Young Women
    Lakehead University Knowledge Commons,http://knowledgecommons.lakeheadu.ca Electronic Theses and Dissertations Retrospective theses 2006 Polymorphic regions of the estrogen receptor, androgen receptor and serotonin transporter genes and their association with mood variability in young women Richards, Meghan A. http://knowledgecommons.lakeheadu.ca/handle/2453/3361 Downloaded from Lakehead University, KnowledgeCommons Polymorphic Regions 1 Ruimmg head: GENETIC POLYMORPHISMS AND MOOD Polymorphic Regions of the Estrogen Receptor, Androgen Receptor and Serotonin Transporter Genes and their Association with Mood Variability in Young Women Meghan A. Richards M.A. Thesis Lakehead University Supervisor: Dr. Kirsten Oinonen copyright © Meghan Richards, 2006 Reproduced with permission of the copyright owner. Further reproduction prohibited without permission. Library and Bibliothèque et 1^1 Archives Canada Archives Canada Published Heritage Direction du Branch Patrimoine de l'édition 395 Wellington Street 395, rue Wellington Ottawa ON K1A 0N4 Ottawa ON K1A 0N4 Canada Canada Your file Votre référence ISBN: 978-0-494-21539-5 Our file Notre référence ISBN: 978-0-494-21539-5 NOTICE: AVIS: The author has granted a non­ L'auteur a accordé une licence non exclusive exclusive license allowing Library permettant à la Bibliothèque et Archives and Archives Canada to reproduce,Canada de reproduire, publier, archiver, publish, archive, preserve, conserve,sauvegarder, conserver, transmettre au public communicate to the public by par télécommunication ou par l'Internet, prêter, telecommunication or on the Internet,distribuer et vendre des thèses partout dans loan, distribute and sell theses le monde, à des fins commerciales ou autres, worldwide, for commercial or non­ sur support microforme, papier, électronique commercial purposes, in microform,et/ou autres formats.
    [Show full text]
  • Early Adversity, Socioemotional Development, and Stress in Urban 1-Year-Old Children
    Early Adversity, Socioemotional Development, and Stress in Urban 1-Year-Old Children Frederick B. Palmer, MD1,2, Kanwaljeet J. S. Anand, MBBS, DPhil1,3,4, J. Carolyn Graff, PhD2,5, Laura E. Murphy, EdD2,6, Yanhua Qu, PhD7, Eszter V€olgyi, PhD7, Cynthia R. Rovnaghi, MS1,4, Angela Moore, MPH7, Quynh T. Tran, PhD7, and Frances A. Tylavsky, DrPH7 Objective To determine demographic, maternal, and child factors associated with socioemotional (SE) problems and chronic stress in 1-year-old children. Study design This was a prospective, longitudinal, community-based study, which followed mother-infant dyads (n = 1070; representative of race, education, and income status of Memphis/Shelby County, Tennessee) from midges- tation into early childhood. Child SE development was measured using the Brief Infant-Toddler Social and Emotional Assessment in all 1097 1-year-olds. Chronic stress was assessed by hair cortisol in a subsample of 1-year-olds (n = 297). Multivariate regression models were developed to predict SE problems and hair cortisol levels. Results More black mothers than white mothers reported SE problems in their 1-year-olds (32.9% vs 10.2%; P < .001). In multivariate regression, SE problems in blacks were predicted by lower maternal education, greater parenting stress and maternal psychological distress, and higher cyclothymic personality score. In whites, predictors of SE problems were Medicaid insurance, higher maternal depression score at 1 year, greater parenting stress and maternal psycho- logical distress, higher dysthymic personality score, and male sex. SE problem scores were associated with higher hair cortisol levels (P = .01). Blacks had higher hair cortisol levels than whites (P < .001).
    [Show full text]
  • Human 5-HT Transporter Availability Predicts Amygdala Reactivityin Vivo
    The Journal of Neuroscience, August 22, 2007 • 27(34):9233–9237 • 9233 Brief Communications Human 5-HT Transporter Availability Predicts Amygdala Reactivity In Vivo Rebecca A. Rhodes,1 Naga Venkatesha Murthy,1,3 M. Alex Dresner,2 Sudhakar Selvaraj,1,4 Nikolaos Stavrakakis,1 Syed Babar,5 Philip J. Cowen,4 and Paul M. Grasby1 1Psychiatry Group, 2Imaging Sciences Department, Medical Research Council (MRC) Clinical Sciences Centre, and 3Experimental Medicine, Psychiatry Clinical Pharmaceology Discovery Medicine, GlaxoSmithKline Clinical Imaging Centre, Imperial College London, London W12 0NN, United Kingdom, 4Department of Psychiatry, University of Oxford, Oxford OX3 7JX, United Kingdom, and 5Radiology Department, Hammersmith Hospital, London W12 0HS, United Kingdom The amygdala plays a central role in fear conditioning, emotional processing, and memory modulation. A postulated key component of the neurochemical regulation of amygdala function is the neurotransmitter 5-hydroxytryptamine (5-HT), and synaptic levels of 5-HT in the amygdala and elsewhere are critically regulated by the 5-HT transporter (5-HTT). The aim of this study was to directly examine the relationship between 5-HTT availability and amygdala activity using multimodal [positron emission tomography (PET) and functional magnetic resonance imaging (fMRI)] imaging measures in the same individuals. Healthy male volunteers who had previously undergone an[ 11C]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile([ 11C]-DASB)PETscantodetermine5-HTTavailabilitycom- pleted an fMRI emotion recognition task. [ 11C]-DASB binding potential values were calculated for the amygdala using arterial input function and linear graphical (Logan) analysis. fMRI was performed on a 3T Philips Intera scanner, and data were analyzed using SPM2 (Wellcome Department Imaging Neuroscience, University College London).
    [Show full text]
  • Contents I. Central Nervous System Diseases Ii
    CONTENTS CONTRIBUTORS xi PREFACE xiii CORRIGENDUM xv I. CENTRAL NERVOUS SYSTEM DISEASES Section Editor: David Wustrow, Pfizer Global Research & Development, Ann Arbor, Michigan 1. Neuronal Nicotinic Acetylcholine Receptor Modulators: Recent Advances and Therapeutic Potential 3 Scott R. Breining, Anatoly A. Mazurov and Craig H. Miller, Targacept, Inc., 200 East First Street, Suite 300, Winston-Salem, NC 27101 2. Recent Advances in Selective Serotonergic Agents 17 Wayne E. Childers, Jr. and Albert J. Robichaud, Chemical & Screening Sciences, Wyeth Research, CN 8000, Princeton, NJ 08543 3. BACE Inhibitors for the Treatment of Alzheimer’s Disease 35 Ellen W. Baxter and Allen B. Reitz, Johnson & Johnson Pharmaceutical Research and Development LLC, Spring House, PA 19477-0776 4. Positron Emission Tomography Agents for Central Nervous System Drug Development Applications 49 N. Scott Masona and Chester A. Mathisa,b,c, aDepartments of Radiology, bPharmacology and cPharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, 15213, USA II. CARDIOVASCULAR AND METABOLIC DISEASES Section Editor: Andrew Stamford, Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 5. Emerging Topics in Atherosclerosis: HDL Raising Therapies 71 Peter J. Sinclair, Merck Research Laboratories, Rahway, NJ 07065, USA v vi Contents 6. Small Molecule Anticoagulant/Antithrombotic Agents 85 Robert M. Scarborough, Anjali Pandey and Xiaoming Zhang, Portola Pharmaceuticals, Inc., 270 East Grand Ave., Suite 22, South San Francisco, CA 94080, USA 7. CB1 Cannabinoid Receptor Antagonists 103 Francis Barth, Sanofi-aventis, 371 rue du Professeur Blayac 34184 Montpellier Cedex 04, France 8. Melanin-Concentrating Hormone as a Therapeutic Target 119 Mark D. McBriar and Timothy J. Kowalski, Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033 9.
    [Show full text]
  • Allostasis, Interoception, and the Free Energy Principle
    1 Allostasis, interoception, and the free energy principle: 2 Feeling our way forward 3 Andrew W. Corcoran & Jakob Hohwy 4 Cognition & Philosophy Laboratory 5 Monash University 6 Melbourne, Australia 7 8 This material has been accepted for publication in the forthcoming volume entitled The 9 interoceptive mind: From homeostasis to awareness, edited by Manos Tsakiris and Helena De 10 Preester. It has been reprinted by permission of Oxford University Press: 11 https://global.oup.com/academic/product/the-interoceptive-mind-9780198811930?q= 12 interoception&lang=en&cc=gb. For permission to reuse this material, please visit 13 http://www.oup.co.uk/academic/rights/permissions. 14 Abstract 15 Interoceptive processing is commonly understood in terms of the monitoring and representation of the body’s 16 current physiological (i.e. homeostatic) status, with aversive sensory experiences encoding some impending 17 threat to tissue viability. However, claims that homeostasis fails to fully account for the sophisticated regulatory 18 dynamics observed in complex organisms have led some theorists to incorporate predictive (i.e. allostatic) 19 regulatory mechanisms within broader accounts of interoceptive processing. Critically, these frameworks invoke 20 diverse – and potentially mutually inconsistent – interpretations of the role allostasis plays in the scheme of 21 biological regulation. This chapter argues in favour of a moderate, reconciliatory position in which homeostasis 22 and allostasis are conceived as equally vital (but functionally distinct) modes of physiological control. It 23 explores the implications of this interpretation for free energy-based accounts of interoceptive inference, 24 advocating a similarly complementary (and hierarchical) view of homeostatic and allostatic processing.
    [Show full text]
  • Current Topics in Behavioral Neurosciences
    Current Topics in Behavioral Neurosciences Series Editors Mark A. Geyer, La Jolla, CA, USA Bart A. Ellenbroek, Wellington, New Zealand Charles A. Marsden, Nottingham, UK For further volumes: http://www.springer.com/series/7854 About this Series Current Topics in Behavioral Neurosciences provides critical and comprehensive discussions of the most significant areas of behavioral neuroscience research, written by leading international authorities. Each volume offers an informative and contemporary account of its subject, making it an unrivalled reference source. Titles in this series are available in both print and electronic formats. With the development of new methodologies for brain imaging, genetic and genomic analyses, molecular engineering of mutant animals, novel routes for drug delivery, and sophisticated cross-species behavioral assessments, it is now possible to study behavior relevant to psychiatric and neurological diseases and disorders on the physiological level. The Behavioral Neurosciences series focuses on ‘‘translational medicine’’ and cutting-edge technologies. Preclinical and clinical trials for the development of new diagostics and therapeutics as well as prevention efforts are covered whenever possible. Cameron S. Carter • Jeffrey W. Dalley Editors Brain Imaging in Behavioral Neuroscience 123 Editors Cameron S. Carter Jeffrey W. Dalley Imaging Research Center Department of Experimental Psychology Center for Neuroscience University of Cambridge University of California at Davis Downing Site Sacramento, CA 95817 Cambridge CB2 3EB USA UK ISSN 1866-3370 ISSN 1866-3389 (electronic) ISBN 978-3-642-28710-7 ISBN 978-3-642-28711-4 (eBook) DOI 10.1007/978-3-642-28711-4 Springer Heidelberg New York Dordrecht London Library of Congress Control Number: 2012938202 Ó Springer-Verlag Berlin Heidelberg 2012 This work is subject to copyright.
    [Show full text]
  • Treating Thyroid Disease: a Natural Approach to Healing Hashimoto's
    Treating Thyroid Disease: A Natural Approach to Healing Hashimoto’s Melissa Lea-Foster Rietz, FNP-BC, BC-ADM, RYT-200 Presbyterian Medical Services Farmington, NM [email protected] Professional Disclosures I have no personal or professional affiliation with any of the resources listed in this presentation, and will receive no monetary gain or professional advancement from this lecture. Talk Objectives • Define hypothyroidism and Hashimoto’s. • Discuss various tests used to identify thyroid disease and when to treat based on patient symptoms • Discuss potential causes and identify environmental factors that contribute to disease • Describe how the gut (food sensitivities) and the adrenals (chronic stress) are connected to Hashimoto’s and how we as practitioners can work to educate patients on prevention before the need for treatment • How the use of adaptogens can enhance the treatment of Hashimoto’s and identify herbs that are showing promise in the research. • How to use food, exercise, and relaxation to improve patient outcomes. Named for Hakuro Hashimoto, a physician working in Europe in the early 1900’s. Hashimoto’s was the first autoimmune disease to be recognized in the scientific literature. It is estimated that one in five people suffer from an autoimmune disease and the numbers continue to rise. Women are more likely than men to develop an autoimmune disease, and it is believed that 75% of individuals with an autoimmune disease are female. Thyroid autoimmune disease is the most common form, and affects 7-8% of the population in the United States. Case Study Ms. R is a 30-year-old female, mother of three, who states that after the birth of her last child two years ago she has felt the following: • Loss of energy • Difficulty losing weight despite habitual eating pattern • Hair loss • Irregular menses • Joints that ache throughout the day • A general sense of sadness • Cold Intolerance • Joint and Muscle Pain • Constipation • Irregular menstruation • Slowed Heart Rate What tests would you run on Ms.
    [Show full text]
  • Characterisation of the Genomic Landscape of CRLF2‐Rearranged Acute Lymphoblastic Leukemia
    Characterisation of the Genomic Landscape of CRLF2- rearranged Acute Lymphoblastic Leukemia Lisa J Russell1*, Lisa Jones1, Amir Enshaei1, Stefano Tonin1, Sarra L Ryan1, Jeyanthy Eswaran1 , Sirintra Nakjang2, Elli Papaemmanuil3,4, Jose M C Tubio4, Adele K Fielding5, Ajay Vora6, Peter J Campbell4, Anthony V Moorman1, and Christine J Harrison1 1 Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK 2 Bioinformatics Support Unit, Newcastle University, Newcastle-upon-Tyne, UK 3 Memorial Sloan Kettering Cancer Center, USA 4 Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK 5 Research Department of Haemaoloty, UCL Cancer Institute, London, UK 6 Department of Haematology, Sheffield Children’s Hospital, Sheffield, UK; AVM and CJH contributed equally to this study Running Title – Genomic landscape of CRLF2 rearranged leukemia Correspondence to: Dr Lisa J Russell, Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Level 6, Herschel Building, Brewery Lane, Newcastle upon Tyne, NE1 7RU, [email protected]. Acknowledgements Support by: The Kay Kendall Leukaemia Fund, Leuka, European Haematology Association and Bloodwise (formerly Leukaemia and Lymphoma Research) This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as an ‘Accepted Article’, doi: 10.1002/gcc.22439 This article is protected by copyright. All rights reserved. Genes, Chromosomes & Cancer Page 2 of 147 Deregulated expression of the type I cytokine receptor, CRLF2, is observed in 5-15% of precursor B-cell acute lymphoblastic leukaemia (B-ALL).
    [Show full text]
  • 17 - 19 October 2019
    THE 12TH INTERNATIONAL SYMPOSIUM ON HEALTH INFORMATICS AND BIOINFORMATICS T G T A A A T G A G A A G T T G G G T A A A A A A A A T T T A A A A A A G G A A A A A A A G G G G G G G G A A A G G G G G G T T G G G G G G G T T T T G G T T G G G T T T G G T A A T T G G T T T A A A A A A A A T T T A A A A A A T T A A A A A A A T A T T T T T T A A A T T T T G T A G A A T T T A A 17 - 19 OCTOBER 2019 HIBIT 2019 ABSTRACT BOOK THE 12TH INTERNATIONAL SYMPOSIUM ON HEALTH INFORMATICS AND BIOINFORMATICS TABLE OF CONTENTS 1 8 WELCOME MESSAGE KEYNOTE LECTURERS 2 19 ORGANIZING COMMITEE INVITED SPEAKERS 3 29 SCIENTIFIC COMMITEE SELECTED ABSTRACTS FOR ORAL PRESENTATIONS 6 61 PROGRAM POSTER PRESENTATIONS Welcome Message The International Symposium on Health Informatics and Bioinformatics, (HIBIT), now in its twelfth year HIBIT 2019, aims to bring together academics, researchers and practitioners who work in these popular and fulfilling areas and to create the much- needed synergy among medical, biological and information technology sectors. HIBIT is one of the few conferences emphasizing such synergy.
    [Show full text]